Berirab P 300 IU Injection 2ml – Human Rabies Immunoglobulin

Berirab P 300 IU Injection 2ml

Berirab P is a human rabies immunoglobulin injection containing antibodies against the rabies virus. It is used as part of post-exposure prophylaxis after potential rabies exposure, alongside rabies vaccination when indicated by a healthcare professional. <Cite refs={["turn711691search25","turn711691search3"]}/>

Key Features

• Provides passive antibodies against the rabies virus.

• Used in the management of potential rabies exposure.

• May be administered alongside rabies vaccine as part of a prescribed treatment plan.

• Requires administration by a qualified healthcare professional.

Product Specifications

• Product Name: Berirab P

• Active Ingredient: Human rabies immunoglobulin

• Strength: 300 IU per 2ml

• Concentration: 150 IU/ml

• Dosage Form: Injection

• Pack Size: 2ml pre-filled syringe

• Manufacturer: CSL Behring GmbH, Germany

• Distributor in Pakistan: Hakimsons Impex (Pvt.) Ltd. <Cite refs={["turn711691search1","turn711691search5","turn711691search6"]}/>

Important Safety Information

• Urgent care: If bitten or scratched by a potentially rabid animal, immediately wash the wound thoroughly with soap and running water for 15 minutes and seek urgent medical assessment.

• Berirab P must be administered by a healthcare professional. The dose and administration technique depend on the patient's circumstances and clinical guidelines.

• It is not a substitute for the full recommended rabies post-exposure treatment plan.

• Do not self-inject or use without medical supervision.

• Check for allergies and other relevant medical history with the treating professional.

Storage

Store and transport according to the manufacturer's current package insert and labelled temperature requirements. Protect the product from inappropriate storage conditions and check the expiry date before use.

Important: Rabies is a life-threatening disease. Do not delay urgent medical care after a possible exposure.